Product
Medium-dose STP0404
1 clinical trial
1 indication
Indication
HIV-1 infectionClinical trial
A Phase 2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Investigate the Antiviral Effect, Safety, Tolerability, and Pharmacokinetics of STP0404 in Treatment-Naïve Adults With HIV-1 InfectionStatus: Recruiting, Estimated PCD: 2024-10-21